Vanguard Group »

Impact Biomedical shares owned by Vanguard Group

Quarter-by-quarter ownership of Impact Biomedical (IBO) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Impact Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Impact Biomedical held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Impact Biomedical by Vanguard Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $69k 103k 0.67
2025-06-30 $21k 32k 0.65
2025-03-31 $110k 126k 0.87